Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10096-020-04024-1 http://scihub22266oqcxt.onion/10.1007/s10096-020-04024-1 32865669!7456660!32865669     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32865669&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Eur+J+Clin+Microbiol+Infect+Dis 2021 ; 40 (2): 413-417 Nephropedia Template TP {{tp|p=32865669|t=2021. Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients |pdf=|usr=}}{{32865669}} gab.com Text Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients JO: Eur J Clin Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32865669 #FOAvip The prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60-76]) were positive within 11-20 days after their discharge, with an event rate of 19.8 (95%CI 2.60-42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria. Twit Text FOAVip Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients ????Eur J Clin Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32865669 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32865669 #FOAvip English Wikipedia <ref>{{Cite pmid|32865669}}</ref> Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients #MMPMID32865669 Du HW; Chen JN; Pan XB; Chen XL; Yixian-Zhang; Fang SF; Li XQ; Xia PC; Gao L; Lin HL; Chen LM; Liu N Eur J Clin Microbiol Infect Dis 2021[Feb]; 40 (2): 413-417 PMID32865669show ga The prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60-76]) were positive within 11-20 days after their discharge, with an event rate of 19.8 (95%CI 2.60-42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria. |Aged[MESH] |COVID-19/*virology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Patient Discharge[MESH] |Prevalence[MESH] |RNA, Viral/*analysis[MESH] |Retrospective Studies[MESH] |Reverse Transcriptase Polymerase Chain Reaction[MESH]Prevalence and outcomes of re-positive nucleic acid tests in discharge(epmc).pdf DeepDyve Pubget Overpricing